7 - 30 June, 2021
| Digital


Longenesis, co-founded by Insilico Medicine and other top-tier biotech players, is a growing digital health company working towards providing a technological bridge between Healthcare institutions and the Biotech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those of need. Our track record includes working with the biomedical organizations and unlocking the potential for accelerating the R&D process around the globe, including National level projects in the Middle East, U.S., EU, and APAC regions.